Scrip Regulatory Affairs is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Email ID
Password
Sign me in automatically next time
RECENT TWEETS    
26 May 2016

 
25 May 2016

Manufacturers of medical devices that use radiofrequencies - such as implantable pulse generators, spinal cord stimulator systems and implantable fluid management pump systems - are being advised to prepare for the 'significant changes' that the new ...

25 May 2016

The French health minister, Marisol Touraine, says that she intends to send the dossiers on the 90 volunteers who took part in the disastrous Phase I FAAH inhibitor study in Rennes to the working groups that have been set up at EU level to look into ...

24 May 2016

India is deliberating a string of initiatives to ensure that drugs for rare diseases reach patients faster and are available at 'reasonable' prices in the country 1 . The US, EU and Japan, among others, have specific legislation to encourage ...

24 May 2016

As promised in mid-April, and just a month away from the UK's yes/no vote on continued membership of the EU, the UK medtech industry association ABHI has completed and released a survey of its members' views on this theme - its second within the ...

25 May 2016

Manufacturers of medical devices that use radiofrequencies - such as implantable pulse generators, spinal cord stimulator systems and implantable fluid management pump systems - are being advised to prepare for the 'significant changes' that the new ...

25 May 2016

The French health minister, Marisol Touraine, says that she intends to send the dossiers on the 90 volunteers who took part in the disastrous Phase I FAAH inhibitor study in Rennes to the working groups that have been set up at EU level to look into ...

24 May 2016

India is deliberating a string of initiatives to ensure that drugs for rare diseases reach patients faster and are available at 'reasonable' prices in the country 1 . The US, EU and Japan, among others, have specific legislation to encourage ...

24 May 2016

As promised in mid-April, and just a month away from the UK's yes/no vote on continued membership of the EU, the UK medtech industry association ABHI has completed and released a survey of its members' views on this theme - its second within the ...

25 May 2016

Manufacturers of medical devices that use radiofrequencies - such as implantable pulse generators, spinal cord stimulator systems and implantable fluid management pump systems - are being advised to prepare for the 'significant changes' that the new ...

25 May 2016

The French health minister, Marisol Touraine, says that she intends to send the dossiers on the 90 volunteers who took part in the disastrous Phase I FAAH inhibitor study in Rennes to the working groups that have been set up at EU level to look into ...

24 May 2016

India is deliberating a string of initiatives to ensure that drugs for rare diseases reach patients faster and are available at 'reasonable' prices in the country 1 . The US, EU and Japan, among others, have specific legislation to encourage ...

23 May 2016

As part of its planned overhaul of the regulatory framework for medicines and medical devices, the New Zealand government says it intends to 'realize New Zealand's potential as a clinical trial destination' by updating the clinical trial regulations ...

25 May 2016

The French health minister, Marisol Touraine, says that she intends to send the dossiers on the 90 volunteers who took part in the disastrous Phase I FAAH inhibitor study in Rennes to the working groups that have been set up at EU level to look into ...

24 May 2016

As promised in mid-April, and just a month away from the UK's yes/no vote on continued membership of the EU, the UK medtech industry association ABHI has completed and released a survey of its members' views on this theme - its second within the ...

16 May 2016

India's new national intellectual property rights (IPR) policy appears to have steered clear of a host of prickly issues pertaining to the pharmaceutical industry for now while standing firm on the need for "strong measures" against attempts to ...

13 May 2016

The US FDA is considering creating a 'dedicated biosimilar unit' that could help the agency better coordinate policy, operations and other biosimilar functions. Agency officials have proposed creating the dedicated unit as part of biosimilar user ...

23 May 2016

The way in which the US Food and Drug Administration is planning to interpret the Biologics Price Competition and Innovation Act's 'transition provisions' for certain protein products would create a 'dead zone' or 'blackout' period for new ...

16 May 2016

India's new national intellectual property rights (IPR) policy appears to have steered clear of a host of prickly issues pertaining to the pharmaceutical industry for now while standing firm on the need for "strong measures" against attempts to ...

05 May 2016

The government commission conducting an inquiry into Australia's intellectual property system has produced an interim report in which it makes a number of recommendations on data exclusivity and patent term extensions that are guaranteed to have the ...

 
22 April 2016
Ashley Yeo
The big event for the UK, of this or any year, will happen in nine weeks' time. The referendum on the UK's continued membership of the European Union is set for June 23, as promised by the Conservative party after it won the 2015 general ...
 
07 July 2015
Maureen Kenny
Regulators face a difficult balancing act in the debate over how to get innovative medicines to ...
 
11 May 2016
The new EU compliance regime implementing the Nagoya Protocol on the use of biological resources ...
01 May 2016
Trial master files (TMFs) provide evidence that drug sponsors complied with regulations and ...
28 April 2016
The UK's early access to medicines scheme (EAMS) has been operational for two years, along with a ...
 
MOST READ
 
The EMA at 20, what's it all about?
17 April 2015
 
Next AdvaMed Chief Is BIO Exec Scott Whitaker US medical device industry association AdvaMed has appointed Scott Whitaker as its next president and CEO 1 . Whitaker, ...
European Biosimilars Trade Group Appoints New Leadership Team The European Biosimilar medicines Group (EBG) has elected Carol Lynch as Chair of the overall sector group and Klaus Martin ...
 
   
© 2016 Informa plc. All rights reserved.
Scrip Regulatory Affairs is part of Pharma Intelligence. Scrip Regulatory Affairs is a trading division of Informa UK Limited, a company registered in England and Wales with company number 1072954 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Informa UK Limited is part of Informa PLC. © Informa UK Limited.